Ontology highlight
ABSTRACT:
SUBMITTER: Shaukat A
PROVIDER: S-EPMC10551868 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
Shaukat Ayesha A Mujeeb Azka A Shahnoor Syeda S Nasser Nathalie N Khan Abdul Moiz AM
Health science reports 20231005 10
Vasomotor symptoms (VMS) are a common and distressing experience during menopause, affecting a significant portion of women. Hormone therapy (HT) has been the traditional treatment, but its limitations and potential risks have led to the search foar non-hormonal alternatives. Recently, the FDA approved Veozah (Fezolinetant) as a promising nonhormonal solution for moderate to severe VMS in menopause. Veozah, an innovative neurokinin 3 (NK3) receptor antagonist, targets the disrupted thermoregulat ...[more]